Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia, Moderate”

Showing 20 of 0 results

Very early researchStudy completedNCT06489015
What this trial is testing

Recombinant Human Serum Albumin in the Treatment of Mild-to-moderate AD (Alzheimer's Disease) Exploratory Clinical Trial

Who this might be right for
Alzheimer's Disease (AD)
Shenzhen Protgen Co., Ltd. 30
Not applicableUnknownNCT03773016
What this trial is testing

Touchscreen Technology and Art for People With Dementia in Care Homes

Who this might be right for
Mild DementiaModerate Dementia
University of Nottingham 12
Large-scale testing (Phase 3)UnknownNCT01094340
What this trial is testing

Thalidomide for Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Banner Health 20
Not applicableStudy completedNCT00211159
What this trial is testing

OmegAD (Omega-3 and Alzheimer's Disease)

Who this might be right for
Alzheimer's Disease
Karolinska University Hospital 204
Testing effectiveness (Phase 2)Study completedNCT01350362
What this trial is testing

Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Noscira SA 306
Early research (Phase 1)Study completedNCT02624778
What this trial is testing

LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 61
Testing effectiveness (Phase 2)Ended earlyNCT01676935
What this trial is testing

This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 349
Testing effectiveness (Phase 2)Ended earlyNCT00960531
What this trial is testing

A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 160
Not applicableLooking for participantsNCT07081750
What this trial is testing

Dyadic Personalized Home-Based Activity Program for Mild-to-Moderate Dementia Patients Post-Discharge

Who this might be right for
Dementia
Fujian Medical University 55
Testing effectiveness (Phase 2)Study completedNCT03748706
What this trial is testing

PTI-125 for Mild-to-moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer Disease
Pain Therapeutics 13
Testing effectiveness (Phase 2)Ended earlyNCT00606476
What this trial is testing

AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 194
Testing effectiveness (Phase 2)UnknownNCT00174525
What this trial is testing

Safety Study of Passive Immunization for Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pharmacology Research Institute
Not applicableStudy completedNCT04570215
What this trial is testing

Digital Interventions in Neuro-Rehabilitation: Gotcha!

Who this might be right for
DementiaAlzheimer DiseaseAnomia
University College, London 48
Large-scale testing (Phase 3)Study completedNCT05686044
What this trial is testing

A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD

Who this might be right for
Alzheimer Disease
Annovis Bio Inc. 351
Large-scale testing (Phase 3)Study completedNCT02079246
What this trial is testing

Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 1,463
Not applicableStudy completedNCT01825317
What this trial is testing

Effect of NeuroAD on Alzheimer Patients

Who this might be right for
Alzheimer's Disease
Neuronix Ltd 32
Large-scale testing (Phase 3)Ended earlyNCT01969136
What this trial is testing

Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
FORUM Pharmaceuticals Inc 403
Large-scale testing (Phase 3)Study completedNCT02585934
What this trial is testing

Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study

Who this might be right for
Alzheimer's Disease
Axovant Sciences Ltd. 1,315
Not applicableNot Yet RecruitingNCT07673263
What this trial is testing

Effects of X Box Kinect 360 in Alzheimer's Disease

Who this might be right for
Alzheimer s Disease
Ziauddin University 38
Early research (Phase 1)Ended earlyNCT02220738
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Who this might be right for
Alzheimer's Disease
AbbVie 19
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation